Evidence map›Paper›PMID 16078137›Full record

ArticlePharmaceutical research2005

Glycyl-L-glutamine disposition in rat choroid plexus epithelial cells in primary culture: role of PEPT2.

Yongjun Hu, Scott M Ocheltree, Jianming Xiang, Richard F Keep, David E Smith

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Protective effects of isothiocyanates on blood-CSF barrier disruption induced by oxidative stress.American journal of physiology. Regulatory, integrative and comparative physiology · 2012
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yongjun HuDepartment of Pharmaceutical Sciences, The University of Michigan, Ann Arbor, Michigan 48109, USA.
Scott M Ocheltree
Jianming Xiang
Richard F Keep
David E Smith
University of Michigan–Ann Arbor · US

Funding

INTERDEPARTMENTAL TRAINING IN PHARMACOLOGICAL SCIENCEST32GM007767 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ISOM, LORI L. · 1985 to 2019
$10.2M
VASCULAR GLUCOSE TRANSPORTERS IN HYPERTENSIONP01HL018575 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GREKIN, ROGER J · 1985 to 2003
$5.5M
Role of PEPT2 in Peptide/Mimetic Disposition-DynamicsR01GM035498 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SMITH, DAVID E · 1988 to 2013
$3.7M
Endothelial Preconditioning and Ischemic Brain InjuryR01NS034709 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KEEP, RICHARD F · 1996 to 2013
$3.6M
NHLBI NIH HHS P01HL018575NIGMS NIH HHS GM07767NIGMS NIH HHS R01 GM035498NIGMS NIH HHS R01GM035498NINDS NIH HHS R01NS034709
6 · The paper itself

Abstract

purposeThe purpose of this research was to determine the polarity and directionality of the PEPT2-mediated uptake and transepithelial transport of the neuropeptide glycyl-L-glutamine (GlyGln) in choroid plexus.

methodsThe transport kinetics of [3H]GlyGln was studied in neonatal rat choroid plexus epithelial cells in primary culture grown on laminin-coated Transwell filter inserts. Using a bicarbonate artificial cerebrospinal fluid (CSF) buffer (pH 7.4) at 37 degrees C, GlyGln studies were performed as a function of time, substrate concentration, and the presence of potential inhibitors (at 1 mM).

resultsGlyGln (2 microM) accumulation was about three to four times greater when introduced from the apical (CSF-facing) as opposed to the basal (blood-facing) side of the cell monolayer, and transepithelial transport was about two times greater in the apical-to-basal direction. The apical uptake of radiolabeled GlyGln (2 microM) was inhibited significantly by dipeptides (i.e., unlabeled GlyGln and cysteinylglycine) and some neuropeptides (i.e., carnosine, N-acetylaspartylglutamate, kyotorphin), but was unaffected by amino acids (i.e., glycine, glutamine) as well as by [D-Arg2]-kyotorphin and glutathione. The concentration-dependent apical uptake of GlyGln (2-1000 microM) was characterized by a high-affinity process (i.e., Vmax of 72 pmol/mg/min; Km of 136 microM), consistent with the properties of PEPT2. The intracellular hydrolysis of GlyGln was extensive, however, with only 40% of the dipeptide remaining intact after 1 h.

conclusionsThe results demonstrate that PEPT2 plays an important role in regulating the apical uptake of GlyGln at the blood-CSF interface. Once inside the cell, GlyGln is rapidly degraded to its constitutive amino acids for further processing.

Indexed as

AnimalsAnimals, NewbornCarnosineCells, CulturedCerebrospinal FluidChoroid PlexusDipeptidesEpithelial CellsKineticsMannitolRatsSarcoglycansSymportersCarnosineDipeptidesglycylglutaminehydrogen-coupled oligopeptide transporter PepT2MannitolSarcoglycansSymporters

Identifiers

PMID16078137
OpenAlexW2029169737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.